Ardelyx Inc (NAS:ARDX)
$ 7.81 0.025 (0.32%) Market Cap: 1.83 Bil Enterprise Value: 1.73 Bil PE Ratio: 0 PB Ratio: 12.11 GF Score: 79/100

Ardelyx Inc at HC Wainwright Kidney Virtual Conference Transcript

Jul 25, 2023 / 06:00PM GMT
Release Date Price: $3.44 (-1.43%)
Unidentified Participant

Hello, and welcome again to the Second Annual H.C. Wainwright Kidney Conference. I'm very pleased to have with us our next presenting company, Ardelyx and representing the company is President and CEO, Mike Raab.

Mike, thank you so much for joining us.

Mike Raab
Ardelyx, Inc. - President & CEO

Of course, and good afternoon, everyone. Thank you, H.C. Wainwright for inviting us to this year's Kidney Conference, and really glad to be here and thank you for putting us on. I think it's a critical focus area that we need to as a society and our business be focused more on what's happening with kidney disease.

And ultimately, patients on dialysis, obviously be making forward-looking statements. So if you need any more information on that, you can see in our 10-Q or at the Ardelyx website.

Now, while most of the time I'll be spending today is going to be focused on XPHOZAH and depending we hope approval on October 17, I do want to spend a little bit of time on IBSRELA. It was approved in and we launched last year in

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot